ARCHIVES

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

‘Major Discover’ At FCRDC Is NF1 Gene, Report Says

November 30, 1990

NCI Division To Promote Funds To Promote Collaboration.

February 18, 2000

In Brief: Weicker Heads New Group For More Spending On Medical Research; Committee Oks Sullivan

March 3, 1989

In Brief: Shingleton To Head AACI; Saunders To Get Two More Jobs At U. Texas Medical Branch

January 21, 1977

Thyroid Cancer Briefing Planned

July 8, 1977

Increased Lung Cancer Risk After Hodgkin’s Treatment

February 22, 2002